文献速递冠心病

侧支循环在稳定性心绞痛中的作用:一项有创安慰剂对照研究

The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study.
PubMed 文献 · Circulation · 2025-10-27

结果显示侧支循环与缺血负担相关,且侧支化程度越高疼痛强度评分越低,提示侧支循环可能减轻缺血性胸痛。

要点

  • 稳定性冠心病患者每日心绞痛频率与缺血严重程度(FFR/iFR)相关性弱。
  • FFR/iFR值越低,侧支血流越多,二者存在强关联证据。
  • 侧支化程度越高,球囊闭塞所致疼痛强度评分越低。

核心结论

  • 冠状动脉侧支化与缺血负担相关,并可能降低缺血性胸痛的强度。
  • 这或可解释狭窄、缺血与心绞痛之间的非线性关系。

研究设计与样本

  • 停用抗心绞痛药物后,用专用智能手机应用记录14天每日心绞痛症状,再行有创压力导丝研究和冠状动脉血流储备评估。
  • 每例患者接受四次60秒低压球囊扩张跨越冠状动脉狭窄,每次与视听一致的安慰剂扩张随机配对。

主要发现

  • 每日心绞痛频率与FFR评估的缺血严重程度相关性弱(Somers' D 0.124,Pr=0.057),与iFR亦弱(Somers' D 0.056,Pr=0.150)。
  • FFR越低与侧支血流越多强关联(Somers' D 0.302,Pr=0.998),iFR越低与侧支血流越多强关联(Somers' D 0.316,Pr=0.999)。
  • 侧支化程度越高(侧支血流指数越高)与疼痛强度评分越低强关联(Somers' D 0.341,Pr=0.999)。
  • 序贯球囊闭塞各次之间疼痛强度评分和侧支血流指数保持稳定,提示缺血预适应证据少。

关键数值与推荐

  • 参与者平均年龄63±9岁,男性占78%。
  • FFR中位数0.68(IQR 0.57-0.79),iFR中位数0.80(IQR 0.48-0.89),冠状动脉血流储备中位数1.42(IQR 1.08-1.85)。

临床怎么用

  • 评估稳定性心绞痛时应关注侧支循环对症状的调节作用,而非仅凭缺血负担判断症状严重程度。
  • 侧支血流指数较高者球囊闭塞所致疼痛强度评分较低,提示侧支循环可能减轻缺血性胸痛。

局限性

  • 仅纳入严重单支冠状动脉病变患者,不适用于多支病变或不同临床情形。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Little correlation exists between the burden of ischemia and severity of angina in patients with stable coronary artery disease. This placebo-controlled, n-of-1 study investigated the relationship between ischemia, the collateral circulation, and symptoms in stable coronary artery disease. Additionally, it explored the association between progressive collateral recruitment and ischemic preconditioning. METHODS: Fifty-one participants with severe single-vessel coronary artery disease and angina were recruited. Antianginal medications were stopped, and daily angina symptoms were documented using a dedicated smartphone application (ORBITA [Objective Randomized Blinded Investigation With Optimal Medical Therapy of Angioplasty in Stable Angina] app) for 14 days before undergoing invasive pressure wire studies and coronary flow reserve assessment. Each participant then underwent four 60-s episodes of low-pressure balloon occlusion across their coronary stenosis. Each episode was paired with an audiovisually identical placebo inflation in a randomized order. After each episode, participants scored pain intensity on a 10-point scale, and a placebo-controlled pain intensity score was calculated. Collateral flow index was calculated from simultaneous measures of aortic, right atrial, and distal coronary wedge pressure during balloon occlusion. Higher Pr values from Bayesian models indicate a greater likelihood of association. RESULTS: The mean (±SD) age of participants was 63±9 years, and 78% were men. The median (interquartile range) fractional flow reserve was 0.68 (0.57-0.79), the median instantaneous wave-free ratio was 0.80 (0.48-0.89), and the median coronary flow reserve was 1.42 (1.08-1.85). Daily angina frequency showed little correlation with severity of ischemia, as assessed by fractional flow reserve (Somers' D 0.124, Pr=0.057) or instantaneous wave-free ratio (Somers' D 0.056, Pr=0.150). However, there was strong evidence of an association between lower fractional flow reserve and instantaneous wave-free ratio values and greater collateral flow (Somers' D 0.302, Pr=0.998 and Somers' D 0.316, Pr=0.999, respectively). There was also strong evidence of an association between more collateralization (higher collateral flow index) and lower pain intensity scores (Somers' D 0.341, Pr=0.999). Finally, pain intensity scores and collateral flow index remained stable between sequential balloon occlusion episodes within individual patients, indicating little evidence of ischemic preconditioning. CONCLUSIONS: Coronary collateralization is associated with ischemic burden and may reduce the intensity of ischemic chest pain. This may explain the nonlinear relationship between stenosis, ischemia, and angina. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04280575.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Rajkumar CA, Foley MJ, Ahmed-Jushuf F, et al. The Role of the Collateral Circulation in Stable Angina: An Invasive Placebo-Controlled Study. Circulation. 2025. PMID: 41144984. doi:10.1161/CIRCULATIONAHA.125.074687

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。